ADHF hospitalizations in the US increased from 2005 to 2014, driven largely by HFpEF, while 1-year survival remained poor overall despite improvements in black patients.
Rising ADHF burden driven by HFpEF warrants monitoring; leaves open optimal prevention and equity-focused strategies to improve survival.
Between 2005 and 2014, trends in ADHF hospitalizations increased in 4 US communities, primarily driven by acute HFpEF. Survival at 1 year was poor regardless of EF but improved over time for black women and black men.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: